694 resultados para Percutaneous
Resumo:
INTRODUCTION AND OBJECTIVES: The aim of the present paper was to report trends in coronary angioplasty for the treatment of ST-elevation myocardial infarction (STEMI) in Portugal. METHODS: Prospective multicenter data from the Portuguese National Registry of Interventional Cardiology (RNCI) and official data from the Directorate-General for Health (DGS) were studied to analyze percutaneous coronary intervention (PCI) procedures for STEMI from 2002 to 2013. RESULTS: In 2013, 3524 primary percutaneous coronary intervention (p-PCI) procedures were performed (25% of all procedures), an increase of 315% in comparison to 2002 (16% of all interventions). Between 2002 and 2013 the rate increased from 106 to 338 p-PCIs per million population per year. Rescue angioplasty decreased from 70.7% in 2002 to 2% in 2013. During this period, the use of drug-eluting stents grew from 9.9% to 69.5%. After 2008, the use of aspiration thrombectomy increased, reaching 46.7% in 2013. Glycoprotein IIb-IIIa inhibitor use decreased from 73.2% in 2002 to 23.6% in the last year of the study. Use of a radial approach increased steadily from 8.3% in 2008 to 54.6% in 2013. CONCLUSION: During the reporting period there was a three-fold increase in primary angioplasty rates per million population. Rescue angioplasty has been overtaken by p-PCI as the predominant procedure since 2006. New trends in the treatment of STEMI were observed, notably the use of drug-eluting stents and radial access as the predominant approach.
Resumo:
Children may benefit from minimally invasive surgery (MIS) in the correction of Morgagni hernia (MH). The present study aims to evaluate the outcome of MIS through a multicenter study. National institutions that use MIS in the treatment of MH were included. Demographic, clinical and operative data were analyzed. Thirteen patients with MH (6 males) were operated using similar MIS technique (percutaneous stitches) at a mean age of 22.2±18.3 months. Six patients had chromosomopathies (46%), five with Down syndrome (39%). Respiratory complaints were the most common presentation (54%). Surgery lasted 95±23min. In none of the patients was the hernia sac removed; prosthesis was never used. In the immediate post-operative period, 4 patients (36%) were admitted to intensive care unit (all with Down syndrome); all patients started enteral feeds within the first 24h. With a mean follow-up of 56±16.6 months, there were two recurrences (18%) at the same institution, one of which was repaired with an absorbable suture; both with Down syndrome. The application of MIS in the MH repair is effective even in the presence of comorbidities such as Down syndrome; the latter influences the immediate postoperative recovery and possibly the recurrence rate. Removal of hernia sac does not seem necessary. Non-absorbable sutures may be more appropriate.
Resumo:
Background. Indirect revascularization is a therapeutic approach in case of severe angina not suitable for percutaneous or surgical revascularization. Transmyocardial revascularization (TMR) is one of the techniques used for indirect revascularization and it allows to create transmyocardial channels by a laser energy bundle delivered on left ventricular epicardial surface. Benefits of the procedure are related mainly to the angiogenesis caused by inflammation and secondly to the destruction of the nervous fibers of the heart. Patients and method. From September 1996 up to July 1997, 14 patients (9 males – 66.7%, mean age 64.8±7.9 years) underwent TMR. All patients referred angina at rest; Canadian Angina Class was IV in 7 patients (58.3%), III in 5 (41.7%). Before the enrollment, coronarography was routinely performed to find out the feasibility of Coronary Artery Bypass Graft (CABG): 13 patients (91,6%) had coronary arteries lesions not suitable for direct revascularization; this condition was limited only to postero-lateral area in one patient submitted to combined TMR + CABG procedures. Results. Mean discharge time was 3,2±1,3 days after surgery. All patients were discharged in good clinical conditions. Perfusion thallium scintigraphy was performed in 7 patients at a mean follow-up of 4±2 months, showing in all but one an improvement of perfusion defects. Moreover an exercise treadmill improvement was observed in the same patients and all of them are in good clinical conditions, with significantly reduced use of active drugs. Conclusion. Our experience confirms that TMR is a safe and feasible procedure and it offers a therapeutic solution in case of untreatable angina. Moreover, it could be a hybrid approach for patients undergoing CABGs in case of absence of vessels suitable for surgical approach in limited areas of the heart.
Resumo:
Mestrado em Tecnologia de Diagnóstico e Intervenção Cardiovascular - Área de especialização: Intervenção Cardiovascular.
Resumo:
Type 1 neurofibromatosis is a relatively common inherited disease of the nervous system, with a frequency of almost 1 in 3000. It is associated with neurofibromas of various sites. Our case report is about the surgical management of a giant neurofibroma of the right gluteal fold in a 46-year-old male with NF1. The patient presented with increasing edema and accelerated growth of the mass; he underwent percutaneous embolization of lesion vessels that induced necrosis of the neurofibroma. The patient was taken to the operating room, where surgical resection of the bulk of the lesion was undertaken. The postoperative course was complicated by delayed wound closure managed with antibiotics and vacuum-assisted wound closure. Giant neurofibromas similar to this tumor require complex preoperative, intraoperative and postoperative management strategies. Surgical debulk is best managed with preoperative percutaneous embolization that help to avoid surgical bleeding. Postoperative delayed wound closure was managed with the application of negative pressure in a closed environment that triggers granulation and tissue formation.
Resumo:
Introduction : Les guides de pratique recommandent que les patients avec une maladie artérielle périphérique (MAP) soient traités médicalement afin de réduire la survenue d’évènements cardiovasculaires majeurs. Objectif : Identifier les facteurs associés à la prescription des thérapies préventives recommandées. Méthode : Les patients avec une MAP (n=362) traités consécutivement par angiodilatation fémoropoplitée entre 2008 et 2010 dans un centre tertiaire (CHU de Québec, Canada) ont été inclus dans l’étude. L’issue clinique primaire était la prescription de trois thérapies combinées. Résultats : Au total, 52% des patients recevaient la thérapie combinée. La présence d’au moins trois facteurs de risque cardiovasculaire (Rapport de cotes (RC)=4,51; IC 95% : 2,76-7,37) était le facteur le plus fortement associé à la prise des thérapies combinées. Conclusion : La prise en charge du risque cardiovasculaire des patients avec une MAP est encore sous-optimale. Une meilleure compréhension des barrières et des facilitateurs à l’application des recommandations est toujours nécessaire.
Resumo:
Coronary heart disease is a major cause of morbidity and mortality worldwide. Percutaneous coronary intervention (PCI) has become the most widely used method of coronary artery revascularisation. The use of stents to hold open atherosclerosis induced arterial narrowing has significantly reduced elastic recoil and acute vessel occlusion following balloon angioplasty. However, bare metal stents have been associated with in-stent restenosis attributed to vascular smooth muscle cell (VSMC) hyperplasia and excessive neointimal formation. The resultant luminal renarrowing may manifest clinically with the return of symptoms such as chest pain or shortness of breath. The development of drug eluting stents has significantly reduced the incidence of in-stent restenosis (ISR). Unfortunately the antiproliferative medications used not only inhibit VSMC proliferation but also re-endothelialisation of the stented vessel. In addition, the drug impregnated polymer coating has been associated with a chronic inflammatory response within the vessel wall predisposing patients to stent thrombosis. Thus the identification of novel therapies which promote vessel healing without excessive proliferative or inflammatory response may improve long term outcome and reduce the need for repeated revascularisation. MicroRNAs (miRs) are short (18-25 nucleotide) non-coding RNAs acting to regulate gene expression. By binding to the 3’untranslated region of mRNA they act to fine tune gene expression either by mRNA degradation or translational repression. Originally identified in coordinating tissue development microRNAs have also been shown to play important roles coordinating the inflammatory response and in numerous cardiovascular diseases. MiR-21 has been identified in human atherosclerotic plaques, arteriosclerosis obliterans and abdominal aortic aneurysms. In addition, its up regulation has been documented in preclinical models of vascular injury. This study sought to identify the role of miR-21 in the development of ISR. Utilising a small animal model of stenting and in vitro techniques, we sought to investigate its influence upon VSMC and immune cell response following stenting. 19 The refinement of a murine stenting model within the Baker laboratory and the electrochemical dissolution of the metal stent from within harvested vascular tissues significantly improved the ability to perform detailed histological analysis. In addition, identification of miRNAs using in situ hybridisation was achieved for the first time within stented tissue. Neointimal formation and ISR was significantly reduced in mice in which miR-21 had been genetically deleted. In addition, neointimal composition was found to be altered in miR-21 KO mice with reductions in VSMC and elastin content demonstrated. Importantly, no difference in re-endothelialisation was observed. In vitro analysis demonstrated that VSMCs from miR-21 KO mice had both reduced proliferative and migratory capacity following platelet derived growth factor stimulation. Molecular analysis revealed that these differences may, at least in part, be due to de-repression of programmed cell death 4 (PDCD4). PDCD4 is a known miR-21 target within VSMCs implicated in the suppression of proliferation and promotion of apoptosis. Unfortunately, initial attempts at antimiR mediated knockdown of miR-21 in vivo, failed to produce a similar change in the suppression of ISR. Furthermore, a significant alteration in macrophage polarisation state within the neointima of miR-21 WT and KO mice was noted. Immunohistochemical staining revealed a preponderance of anti-inflammatory M2 macrophages in KO mice. Analysis of bone marrow derived macrophages from miR-21 KO mice demonstrated an increased level of the peroxisome proliferation activating receptor-γ (PPARγ) which facilitates M2 polarisation. Importantly, significant alterations in numerous pro-inflammatory cytokines, which also have mitogenic effects, were also found following genetic deletion of miR-21. In Summary, this is the first study to look at miRs in the development of ISR. MiR-21 plays an important role in the development of ISR by influencing the proliferative response of VSMCs and modulating the immune response following stent deployment. Further attempts to modulate miR-21 expression following PCI may reduce ISR and the need for repeat revascularisation while also reducing the risk of stent thrombosis.
Resumo:
Children may benefit from minimally invasive surgery (MIS) in the correction of Morgagni hernia (MH). The present study aims to evaluate the outcome of MIS through a multicenter study. National institutions that use MIS in the treatment of MH were included. Demographic, clinical and operative data were analyzed. Thirteen patients with MH (6 males) were operated using similar MIS technique (percutaneous stitches) at a mean age of 22.2±18.3 months. Six patients had chromosomopathies (46%), five with Down syndrome (39%). Respiratory complaints were the most common presentation (54%). Surgery lasted 95±23min. In none of the patients was the hernia sac removed; prosthesis was never used. In the immediate post-operative period, 4 patients (36%) were admitted to intensive care unit (all with Down syndrome); all patients started enteral feeds within the first 24h. With a mean follow-up of 56±16.6 months, there were two recurrences (18%) at the same institution, one of which was repaired with an absorbable suture; both with Down syndrome. The application of MIS in the MH repair is effective even in the presence of comorbidities such as Down syndrome; the latter influences the immediate postoperative recovery and possibly the recurrence rate. Removal of hernia sac does not seem necessary. Non-absorbable sutures may be more appropriate.
Resumo:
As Síndromes Coronárias Agudas (SCA) são responsáveis por elevadas taxas de mortalidade em todo o mundo. Segundo o Ministério da Saúde, “as doenças cardiovasculares (…) são a principal causa de mortalidade em Portugal, tal como se verifica em muitos países ocidentais, sendo considerada, no entanto, das mais elevadas da Europa e do Mundo” (MINISTÉRIO DA SAÚDE, 2006, p. 2). As intervenções de enfermagem na fase aguda das SCA são fulcrais e consistem na atenção dirigida à proteção e promoção da vida com base nas suas competências específicas, alívio da dor e desenvolvimento de uma relação terapêutica que passa pela consciencialização da necessidade de alterações dos hábitos não saudáveis de vida entre as pessoas internadas. Estas intervenções devem iniciar-se precocemente através de um processo de identificação e reconhecimento da necessidade de alterações comportamentais, educação para a saúde e planeamento do regime terapêutico, favorecendo a adesão a programas de reabilitação cardíaca. Verificamos que muitas das admissões no serviço de cardiologia, por SCA, são reinternamentos, sugerindo que a vigilância à saúde pode não ser a mais adequada. Neste trabalho pretende-se a partilha da experiência de educação para a saúde à pessoa com SCA no serviço de cardiologia de um hospital da região metropolitana de Lisboa. O serviço de cardiologia do HFF tem desenvolvido desde o ano 2000 um programa de educação para a saúde nas pessoas com SCA com extensão às suas famílias. Consistia, inicialmente, numa intervenção iniciada à cabeceira do doente como processo natural de educação para a saúde e, por ocasião da passagem pela enfermaria, com a apresentação de uma sessão em PowerPoint e disponibilização de um manual em formato papel. Ao longo dos anos o programa vem sofrendo modificações para melhor adequação às necessidades de educação para a saúde do indivíduo. Refletimos acerca da pertinência destas intervenções, o seu impacto sobre a saúde das pessoas e a relevância em termos de alteração de hábitos não saudáveis de vida entre os doentes internados. Neste processo de reformulação do programa, analisamos os processos hospitalares dos doentes submetidos às sessões de educação para a saúde num intervalo de 6 meses (janeiro a junho de 2014) e efetuamos entrevistas telefónicas a esta população um ano após a data do internamento. Dos dados analisados percebemos que uma parcela significativa destas pessoas não se lembrava da sessão de educação para a saúde. Por outro lado, das que se recordavam, revelaram o relevante impacto da educação para a saúde na alteração de hábitos não saudáveis de vida. A análise dos dados permitiu a reorganização das sessões de educação para a saúde desde o seu conteúdo até à metodologia. Ainda muitos passos devem ser dados no aperfeiçoamento deste projecto. Pretendemos elaborar um protocolo que permita uniformizar a prática de educação para a saúde e introduzir instrumentos de avaliação em cada etapa do mesmo. BIBLIOGRAFIA Cossette, S., D´Aoust, L.-X., Morin, M., Heppell, S., & Frasure-Smith, N. (2009). The Systematic Development of a Nursing Intervention Aimed at Increasing Enrollment in Cardiac Rehabilitation for Acute Coronary Syndrome Patients. Progress in Cardiovascular Nursing, 24, pp. 71-79. Fernandez, R., Davidson, P., Griffiths, R., Juergens, C., & Salamonson, Y. (2007). What do we know about the long term medication adherence in patients following percutaneous coronary intervention? Australian Journal of Advanced Nursing, 25 (2), pp. 53-61. Ministério da Saúde. (2006). Programa Nacional de Prevenção e Controlo das Doenças Cardiovasculares. Lisboa. Mota, T. G., Clara, J. G., Gonçalves, J. V., Rocha, A. P., Neves, A. P., & Santos, T. M. (2003). Passaporte para a Vida. Coimbra: Grupo de Estudos de Hemodinâmica e Cardiologia de Intervenção da Sociedade Portuguesa de Cardiologia. Ordem dos Enfermeiros. (2003). Competências do enfermeiro de cuidados gerais. Lisboa. Santos, L. S., & Henriques, E. (2012). Gestão do regime terapêutico no pós- EAM: desenvolvimento de um protocolo de intervenção de enfermagem em follow-up. Relatório de Estágio de Mestrado, Escola Superior de Enfermagem de Lisboa, Lisboa. Thelan, L. A., Davie, J. K., Urden, L. D., & Lough, M. E. (1996). Enfermagem em Cuidados Intensivos ̶ Diagnóstico e Intervenção. Lisboa: Lusodidacta. Urden, L. D., Stacy, K. M., & Lough, M. E. (2008). Thelan´s Enfermagem de Cuidados Intensivos ̶ Diagnóstico e Intervenção. Loures: Lusodidacta.
Resumo:
Introdução: O aumento da gordura abdominal e o sedentarismo contribuem para o risco de doença cardiovascular. A utilização de corrente elétrica de baixa intensidade (microcorrente) na região abdominal, associado ao exercício físico, parece ser um método inovador no aumento da taxa lipolítica dos adipócitos abdominais. Objetivos: Analisar os efeitos da utilização da microcorrente associada a um programa de exercícios em indivíduos saudáveis e com doença arterial coronária na gordura abdominal, e ainda, analisar os efeitos de um programa de exercício físico específico realizado no domicílio em indivíduos com doença arterial coronária, na fase de manutenção da reabilitação cardiovascular, na capacidade cardiorrespiratória. Métodos: Foram conduzidos três estudos: Estudo 1, em indivíduos saudáveis, durante 5 semanas (n=42), distribuídos aleatoriamente por quatro grupos experimentais (realizavam microcorrente e exercício físico: grupo 1- frequência 25 a 10Hz, elétrodos transcutâneos, exercício físico após; grupo 2- frequência 25 a 50Hz, elétrodos trancutâneos, exercício físico após; grupo 3- frequência 25 a 10Hz, elétrodos percutâneos e exercício físico após; grupo 4- frequência 25 a 10Hz, elétrodos transcutâneos e exercício físico realizado em simultâneo) e placebo (realizavam apenas exercício físico), onde foram avaliadas medidas de gordura abdominal; Estudo 2, em indivíduos saudáveis, durante uma sessão de microcorrente e exercício físico (n=83), distribuídos aleatoriamente por grupo experimental (realizavam microcorrente e exercício físico) e grupo placebo (realizavam exercício físico), onde foram avaliadas a atividade lipolítica (níveis de glicerol) e a oxidação de ácidos gordos (estimada pelo VO2 e VCO2); Estudo 3, em indivíduos após um ano de evento de síndrome coronária aguda (n=44), distribuídos aleatoriamente em dois grupos experimentais (grupo 1- exercício físico no domicílio; grupo 2- microcorrente e exercício físico no domicílio) e um grupo controlo (cuidados habituais), durante 8 semanas, sendo avaliados a gordura abdominal, o colesterol, a capacidade cardiorrespiratória, os hábitos de atividade física e alimentares e a qualidade de vida. Resultados: No estudo 1, após 5 semanas de intervenção de microcorrente e exercício físico, verificou-se uma redução das medidas de gordura abdominal (p<0,05); No estudo 2 observou-se que uma sessão de microcorrente associada ao exercício físico aumentou a taxa lipolítica, através da medição de glicerol (p<0,05), sem alterações significativas na oxidação de ácidos gordos, durante o exercício. No estudo 3, após as 8 semanas de aplicação de microcorrente associada a um programa de exercícios específicos no domicílio ocorreu uma diminuição significativa na gordura subcutânea (p<0,05). O programa de exercício físico de reabilitação cardiovascular no domicílio, per se, aumentou a capacidade cardiorrespiratória, na fase de manutenção (p<0,05). Não se verificaram alterações do colesterol total, dos hábitos alimentares, da atividade física e da qualidade de vida entre os três grupos. Conclusão: A utilização da microcorrente associada ao exercício físico parece ser um meio coadjuvante ao programa de exercícios, na redução do tecido adiposo abdominal em indivíduos saudáveis e em indivíduos após 1 ano de enfarte agudo do miocárdio. O programa de Reabilitação Cardiovascular no domicílio, em fase de manutenção, demonstrou melhoria da capacidade cardiorrespiratória.
Resumo:
Background It is unclear how dysphagic patients should be fed and treated after acute stroke. Objectives The objective of this review was to assess the effect of different management strategies for dysphagic stroke patients, in particular how and when to feed, whether to supplement nutritional intake, and how and whether to treat dysphagia. Search strategy We searched the Cochrane Stroke Group trials register, Medline, Embase, ISI, and existing review articles.We contacted researchers in the field and equipment manufacturers. Date of the most recent searches: March 1999. Selection criteria Unconfounded truly or quasi randomised controlled trials in dysphagic patients with acute/subacute (within 3 months) stroke. Data collection and analysis Three reviewers independently applied the trial inclusion criteria. Two reviewers assessed trial quality and extracted the data. Main results Percutaneous endoscopic gastrostomy (PEG) versus nasogastric tube (NGT) feeding: two trials (49 patients) suggest that PEG reduces end-of-trial case fatality (Peto Odds Ratio, OR 0.28, 95% CI 0.09 to 0.89) and treatment failures (OR 0.10, 95% CI 0.02 to 0.52), and improves nutritional status, assessed as weight (Weighted Men Difference, WMD +4.1 kg, 95% CI -4.3 to +12.5), mid-arm circumference (WMD +2.2 cm, 95% CI -0.5 to +4.9) or serum albumin (WMD + 7.0 g/l, 95% CI +4.9 to +9.1) as compared with NGT feeding; two larger studies are ongoing. Timing of feeding: no completed trials; one large study is ongoing. Swallowing therapy for dysphagia: two trials (85 patients) suggest that formal swallowing therapy does not significantly reduce end-of-trial dysphagia rates (OR 0.55, 95%CI 0.18 to 1.66). Drug therapy for dysphagia: one trial (17 patients); nifedipine did not alter end-of-trial case fatality or the frequency of dysphagia. Nutritional supplementation: one trial (42 patients) found a non-significant trend to a lower case fatality, and significantly increased energy and protein intake; one large trial is ongoing and data is awaited from two other studies. Fluid supplementation: one trial (20 patients) found that supplementation did not alter the time to resolution of dysphagia. Authors’ conclusions Too few studies have been performed, and these have involved too few patients. PEG feeding may improve outcome and nutrition as compared with NGT feeding. Further research is required to assess how and when patients are fed, and the effect of swallowing or drug therapy on dysphagia.
Resumo:
Background: Perimembranous Ventricular Septal Defect (PMVSD) is the most common subtype of ventricular septal defects. Transcatheter closure of PMVSD is a challenging procedure in management of moderate or large defects. Objectives: The purpose of this study was to show that transcatheter closure of perimembranous ventricular septal defect with Amplatzer Ductal Occluder (ADO) is an effective and safe method. Patients and Methods: Between April 2012 and April 2013, 28 patients underwent percutaneous closure of PMVSD using ADO. After obtaining the size of VSD from the ventriculogram a device at least 2 mm larger than the narrowest diameter of VSD at right ventricular side was chosen. The device deployed after confirmation of its good position by echocardiography and left ventriculography. Follow up evaluations were done 1 month, 6 months, 12 months and yearly after discharge with transthoracic echocardiography and 12 lead electrocardiography. Results: The mean age of patients at procedure was 4.7 ± 6.3 (range 2 to 14) years, mean weight 14.7 ± 10.5 (range 10 to 40) kg. The mean defect size of the right ventricular side was 4.5 ± 1.6 mm. The average device size used was 7.3 ± 3.2mm (range 4 to 12 mm). The ADOs were successfully implanted in all patients. The VSD occlusion rate was 65.7% at completion of the procedure, rising up to 79.5% at discharge and 96.4% during follow-up. Small residual shunts were seen at completion of the procedure, but they disappeared during follow-up in all but one patient. The mean follow-up period was 8.3 ± 3.6 months (range 1 to 18 months). Complete atrioventricular block (CAVB), major complication or death was not observed in our study. Conclusions: Transcatheter closure of PMVSD with ADO in children is a safe and effective treatment associated with excellent success and closure rates, but long-term follow-up in a large number of patients would be warranted.
Resumo:
Pediatric coronary artery bypass surgery gained wide acceptance with the introduction of internal thoracic arteries (ITAs) for bypass operations for post Kawasaki disease (KD) lesions. The technique is now established as the standard surgical choice, and its safety even in infancy, graft patency, growth potential, graft longevity and clinical efficacy have been well documented. In this article the author reviews the development of pediatric coronary bypass as the main indication for the treatment of coronary lesions due to KD. I believe that coronary revascularization surgery in pediatric population utilizing uni- or bilateral ITAs is the current gold-standard as the most reliable treatment, although percutaneous coronary intervention with or without a stent has been tried with vague long-term results in children.
Resumo:
To evaluate the possible blink reflex responses in facial muscles reinnervated by the accessory nerve. Method: Eleven patients with a complete facial palsy were submitted to a surgical repair by an accessory facial nerve anastomosis (AFA). In this pathological group, blink reflex was studied by means of percutaneous electrical stimulation of the supraorbital nerve and recording from the orbicularis oculi muscle. A control group comprised seven normal people and seven patients with a complete Bell's facial palsy; in this group, responses on the sternocleidomastoideus (SCM) muscles were studied after supraorbital nerve stimulation. Results: All the patients with AFA showed a consistent degree of facial reinnervation. Ten out of the 11 patients with AFA showed reflex responses; in six, responses were configured by a double component pattern, resembling the R1 and R2 components of the blink reflex; three patients had an R1-like response and one patient showed a unique R2 component. Mean values of latencies were 15.2 (SD 4.6) ms for the R1 and 85.3 (SD 9.6) ms for the R2. In the control group, eight out of 14 people had evidence of reflex responses in the SCM muscles; these were almost exclusively configured by a bilateral late component (mean latency 63.5 (SD 15.9) ms) and only one of the subjects showed an early response at 11 ms. Conclusion: The trigemino-accessory reflex response in the pathological group was more complex and of a significantly higher incidence than in the control group. These differences could be tentatively explained by a mechanism of synaptic plasticity induced by the impairment of the efferent portion of the reflex. This could unmask the central linking between the trigeminal and the accessory limbs of the reflex. The findings described could be a demonstration of neurobionomic function in the repairing process of the nervous system.
Resumo:
The goal of this trial was to study the long-term effects of intravenous (IV) metoprolol administration before reperfusion on left ventricular (LV) function and clinical events. Early IV metoprolol during ST-segment elevation myocardial infarction (STEMI) has been shown to reduce infarct size when used in conjunction with primary percutaneous coronary intervention (pPCI). The METOCARD-CNIC (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction) trial recruited 270 patients with Killip class ≤II anterior STEMI presenting early after symptom onset (<6 h) and randomized them to pre-reperfusion IV metoprolol or control group. Long-term magnetic resonance imaging (MRI) was performed on 202 patients (101 per group) 6 months after STEMI. Patients had a minimal 12-month clinical follow-up. Left ventricular ejection fraction (LVEF) at the 6 months MRI was higher after IV metoprolol (48.7 ± 9.9% vs. 45.0 ± 11.7% in control subjects; adjusted treatment effect 3.49%; 95% confidence interval [CI]: 0.44% to 6.55%; p = 0.025). The occurrence of severely depressed LVEF (≤35%) at 6 months was significantly lower in patients treated with IV metoprolol (11% vs. 27%, p = 0.006). The proportion of patients fulfilling Class I indications for an implantable cardioverter-defibrillator (ICD) was significantly lower in the IV metoprolol group (7% vs. 20%, p = 0.012). At a median follow-up of 2 years, occurrence of the pre-specified composite of death, heart failure admission, reinfarction, and malignant arrhythmias was 10.8% in the IV metoprolol group versus 18.3% in the control group, adjusted hazard ratio (HR): 0.55; 95% CI: 0.26 to 1.04; p = 0.065. Heart failure admission was significantly lower in the IV metoprolol group (HR: 0.32; 95% CI: 0.015 to 0.95; p = 0.046). In patients with anterior Killip class ≤II STEMI undergoing pPCI, early IV metoprolol before reperfusion resulted in higher long-term LVEF, reduced incidence of severe LV systolic dysfunction and ICD indications, and fewer heart failure admissions.